These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 20719260)
1. One hundred and seven member family with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: Is this a new syndrome-MEN 2C? Shifrin AL; Fay AM; Xenachis CZ; Vernick JJ Surgery; 2010 Sep; 148(3):611-2. PubMed ID: 20719260 [No Abstract] [Full Text] [Related]
2. One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome-MEN 2C? Bhargav PR Surgery; 2010 Sep; 148(3):610-1. PubMed ID: 20719259 [No Abstract] [Full Text] [Related]
3. One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C? Shifrin AL; Xenachis C; Fay A; Matulewicz TJ; Kuo YH; Vernick JJ Surgery; 2009 Dec; 146(6):998-1005. PubMed ID: 19958926 [TBL] [Abstract][Full Text] [Related]
5. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds. Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480 [TBL] [Abstract][Full Text] [Related]
6. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma. Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103 [TBL] [Abstract][Full Text] [Related]
7. [Phenotypic expression of a mutation in MEN 2A documented in a family in the western part of Sweden]. Lindskog S; Ahlman H; Illerskog A; Nilsson O; Nilsson B; Tisell LE; Ysander L; Jansson S Lakartidningen; 2001 Aug; 98(35):3690-1, 3694-5. PubMed ID: 11577645 [TBL] [Abstract][Full Text] [Related]
8. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation. Milos IN; Frank-Raue K; Wohllk N; Maia AL; Pusiol E; Patocs A; Robledo M; Biarnes J; Barontini M; Links TP; de Groot JW; Dvorakova S; Peczkowska M; Rybicki LA; Sullivan M; Raue F; Zosin I; Eng C; Neumann HP Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325 [TBL] [Abstract][Full Text] [Related]
10. Multiple endocrine neoplasia type 2A in a kindred with C634Y mutation. Jackson MB; Guttenberg M; Hedrick H; Moshang T Pediatrics; 2005 Sep; 116(3):e468-71. PubMed ID: 16099853 [TBL] [Abstract][Full Text] [Related]
11. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations. Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097 [TBL] [Abstract][Full Text] [Related]
12. [Neural crest and multiple endocrinopathies]. Pasini A; Michiels FM; Chappuis-Flament S; Geneste O; Rossel M; Fournier L; Feunteun J; Lenoir G; Schuffenecker I; Billaud M C R Seances Soc Biol Fil; 1996; 190(5-6):557-67. PubMed ID: 9074721 [TBL] [Abstract][Full Text] [Related]
13. [Multiple endocrine neoplasia type 2a and 2b]. Vestergaard P Ugeskr Laeger; 1996 Jan; 158(5):590-3. PubMed ID: 8607216 [TBL] [Abstract][Full Text] [Related]
14. [Surgical management of hereditary medullary carcinoma of the thyroid in patients with "RET" proto-oncogene mutation]. Calbo L; Spinelli C; Lazzara S; Melita P; Miccoli P Chir Ital; 1998; 50(5-6):47-51. PubMed ID: 10392193 [TBL] [Abstract][Full Text] [Related]
16. Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma. Marsh DJ; Andrew SD; Eng C; Learoyd DL; Capes AG; Pojer R; Richardson AL; Houghton C; Mulligan LM; Ponder BA; Robinson BG Cancer Res; 1996 Mar; 56(6):1241-3. PubMed ID: 8640806 [TBL] [Abstract][Full Text] [Related]
17. Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside. Machens A; Dralle H Mol Cell Endocrinol; 2006 Mar; 247(1-2):34-40. PubMed ID: 16343738 [TBL] [Abstract][Full Text] [Related]
18. [Genetic analysis of RET mutations in families with multiple endocrine neoplasia type II in the community of Murcia]. Pomares Gómez FJ; Bernabé Espinosa MJ; Matías-Guiu Guía X; Rodríguez González JM; Soriano Palao J; Sola Pérez J; Carbonell Meseguer P; Parrilla Paricio P; Tébar Massó FJ Med Clin (Barc); 1999 May; 112(17):646-50. PubMed ID: 10374185 [TBL] [Abstract][Full Text] [Related]
19. Surgical management of MEN-1 and -2: state of the art. Akerström G; Stålberg P Surg Clin North Am; 2009 Oct; 89(5):1047-68. PubMed ID: 19836484 [TBL] [Abstract][Full Text] [Related]
20. Coexistence of MEN 2A and papillary thyroid carcinoma and a recurrent pheochromocytoma 23 years after surgery: report of a case and a review of the Japanese literature. Oishi S; Sasaki M; Sato T; Isogai M Jpn J Clin Oncol; 1995 Aug; 25(4):153-8. PubMed ID: 7666591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]